Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma

被引:29
作者
Goto, Y
Sueoka, E
Chiba, H
Fujiki, H
机构
[1] Saitama Canc Ctr, Res Inst, Ina, Saitama 3620806, Japan
[2] Tokyo Med Univ, Dept Oral & Maxillofacial Surg, Shinjuku Ku, Tokyo 1600023, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1999年 / 90卷 / 12期
关键词
oral precancerous lesion; oral leukoplakia; cytodiagnosis; biomarker; chemoprevention;
D O I
10.1111/j.1349-7006.1999.tb00720.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of an early tumor detection marker for oral cancer is an obvious need due to the high recurrence rate and poor survival rate. Based on our previous report that overexpression of heterogeneous nuclear ribonucleoprotein (hnRNP) B1 protein was found in 100% of squamous cell carcinomas of human lung, we applied the same immunohistochemical method, using anti-hnRNP B1 antibody, to human oral squamous cell carcinoma (OSCC), Seven human tissue sections of OSCC showed strong staining with anti-hnRNP B1 antibody, and hnRNP B1 protein of 37 kDa was identified in protein fractions isolated from six of the cancerous tissue sections, while it was not found in adjacent noncancerous tissue. Moreover, three non-homogeneous (nodular) leukoplakia sections showed significant anti-hnRNP B1 staining. The results suggest that this antibody detects precancerous lesions as well as advanced lesions (stages I to IV) of OSCC, We also present positive results of cytodiagnosis for two smear specimens. All of the above results indicate that hnRNP B1 is a new and useful marker for early detection of OSCC.
引用
收藏
页码:1358 / 1363
页数:6
相关论文
共 19 条
  • [1] CARCINOEMBRYONIC ANTIGEN, A HUMAN-TUMOR MARKER, FUNCTIONS AS AN INTERCELLULAR-ADHESION MOLECULE
    BENCHIMOL, S
    FUKS, A
    JOTHY, S
    BEAUCHEMIN, N
    SHIROTA, K
    STANNERS, CP
    [J]. CELL, 1989, 57 (02) : 327 - 334
  • [2] IMMUNOHISTOCHEMICAL DEMONSTRATION OF EPITHELIAL GLUTATHIONE-S-TRANSFERASE ISOENZYMES IN NORMAL, BENIGN, PREMALIGNANT AND MALIGNANT HUMAN ORAL-MUCOSA
    CHEN, YK
    LIN, LM
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1995, 24 (07) : 316 - 321
  • [3] CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
  • [4] DOWECK I, 1995, ARCH OTOLARYNGOL, V121, P177
  • [5] FISCHBACH W, 1990, CANCER, V65, P1321, DOI 10.1002/1097-0142(19900315)65:6<1321::AID-CNCR2820650612>3.0.CO
  • [6] 2-Y
  • [7] HIRATA S, 1992, CANCER, V70, P2381, DOI 10.1002/1097-0142(19921115)70:10<2381::AID-CNCR2820701002>3.0.CO
  • [8] 2-9
  • [9] OBSERVER VARIABILITY IN THE HISTOLOGIC ASSESSMENT OF ORAL PREMALIGNANT LESIONS
    KARABULUT, A
    REIBEL, J
    THERKILDSEN, MH
    PRAETORIUS, F
    NIELSEN, HW
    DABELSTEEN, E
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1995, 24 (05) : 198 - 200
  • [10] Kelloff GJ, 1996, J CELL BIOCHEM, P1